 BOULDER, Colo.--BUSINESS WIRE--- BDSX patientsfirst--Biodesix, Inc. Nasdaq: BDSX, a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present in a fireside chat at the BTIG MedTech, Digital Health, Life Science Diagnostic Tools Conference being held virtually February 15-17, 2022. BTIG MedTech, Digital Health, Life Science Diagnostic Tools Conference Date: Wednesday, February 16, 2022 Time: 4:30 PM ET 